ENPP4 and HOXA3 as potential leukaemia stem cell markers in acute myeloid leukaemia

ENPP4 and HOXA3 as potential leukaemia stem cell markers in acute myeloid leukaemia

Introduction: Acute myeloid leukaemia (AML) is a heterogeneous malignant disease with a high degree of treatment failure using chemotherapy. Leukaemia stem cells (LSCs) are CD34+CD38- early progenitors associated with poor prognosis in AML. A unique LSC phenotype that excludes rare normal haematopoi...

Full description

Bibliographic Details
Main Authors:	Mohd Amin, A, Panneerselvan, N, Md Noor, S, Mohtaruddin, N, Sathar, J, Norbaya, WS, Osman, R, Kee, LH, Mohd Yaaku, WH, Cheong, SK, Abdullah, M
Format:	Article
Published:	Malaysian Society of Pathologists 2023

Similar Items

Expression of potential stem cell-related markers in acute myeloid leukaemia cell lines and gene silencing effect of HOXA3 in THP-1 cells
by: Panneerselvan, Hindhuja
Published: (2021)

Investigating super-enhancer-associated chromatin interactions at the HOXA9-MEIS1 oncogene signalling axis in myeloid leukaemia
by: Wang, Benny Zheng Jie
Published: (2020)

Less utilized prognostic markers in acute myeloid leukaemia
by: Abdullah, Maha
Published: (2016)

Harnessing the graft-versus-leukaemia effect in acute myeloid leukaemia
by: Sweeney, C
Published: (2021)

Clonal structures of leukaemia stem cell populations in myeloid blast phase chronic myeloid leukaemia
by: Karamitros, D, et al.
Published: (2016)

Secondary acute myeloid leukaemia in children treated for acute lymphoblastic leukaemia.
by: Eden, O, et al.
Published: (1998)

Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia.
by: Guinn, B, et al.
Published: (2005)

Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
by: Boultwood, J, et al.
Published: (2004)

Amplification of mitochondrial DNA in acute myeloid leukaemia.
by: Boultwood, J, et al.
Published: (1996)

Immunological weapons against acute myeloid leukaemia.
by: Galea-Lauri, J
Published: (2002)

C/EBPalpha mutations in acute myeloid leukaemias.
by: Nerlov, C
Published: (2004)

EVI1 expression in acute myeloid leukaemia.
by: Langabeer, SE, et al.
Published: (2001)

New Therapeutic Approaches for Acute Myeloid Leukaemia
by: Ruth M Risueno, et al.
Published: (2021-06-01)

A rare case of an elderly male with progression to chronic myeloid leukaemia secondary to chronic lymphocytic leukaemia
by: Sakditad Saowapa, et al.
Published: (2024-03-01)

Prediction of acute myeloid leukaemia risk in healthy individuals
by: Abelson, S, et al.
Published: (2018)

Leukaemia.
by: Kinlen, L
Published: (1994)

Neonatal leukaemia
by: Roberts, I, et al.
Published: (2018)

Improved outcome of acute myeloid leukaemia in Down's syndrome.
by: Craze, J, et al.
Published: (1999)

Randomised studies in acute myeloid leukaemia: the double truth
by: Richards, S
Published: (2000)

Analysis of GATA-1 mutations in chronic myeloid leukaemia.
by: Halsey, C, et al.
Published: (2006)

GATA1 mutational analysis in chronic myeloid leukaemia.
by: Halsey, C, et al.
Published: (2007)

Alternative splicing in human myeloid cell differentiation and leukaemia
by: Lim, Kai Yi
Published: (2021)

The genetics of chronic myeloid leukaemia and recent advancements in therapy
by: Alexander Wellington
Published: (2022-06-01)

Prognostic Markers Of Resistance And Relapse In Acute Leukaemia
by: Pon, Maha Abdullah@Maha-Lakswmi
Published: (2003)

Cell viability of acute myeloid leukaemia blasts in culture correlates with treatment outcome
by: Abdullah, Maha, et al.
Published: (2008)

Transformation of myelodysplastic syndrome (MDS) to acute myeloid leukaemia (AML)
by: Goh, Chermaine Yu Zhen
Published: (2021)

Acute myeloid leukaemia in childhood: the costs and benefits of intensive treatment.
by: Phillips, M, et al.
Published: (1991)

The molecular and cellular basis for oncogene collaboration in acute myeloid leukaemia
by: Di Genua, C
Published: (2018)

GATA1 and cooperating mutations in myeloid leukaemia of Down syndrome
by: Garnett, C, et al.
Published: (2019)

Chemotherapy of acute myeloid leukaemia in adults: Medical Research Council.
by: Cuckle, H, et al.
Published: (1979)

Proteomic profile of acute myeloid leukaemia: a review update
by: Almaiman, Amer Abdulrahman, et al.
Published: (2016)

Identification of differentially expressed proteins as biomarkers of acute myeloid leukaemia
by: Barantalab, Fatemeh
Published: (2014)

Recent advances in diagnosis of acute myeloid leukaemia : a review.
by: Ambayya, Angeli, et al.
Published: (2013)

Selection of reference genes for quantitative studies in acute myeloid leukaemia
by: Lee, Cindee, et al.
Published: (2019)

Relapsed pediatric acute myeloid leukaemia: state-of-the-art in 2023
by: Grace Egan, et al.
Published: (2023-03-01)

Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemia
by: Gus O. Nwosu, et al.
Published: (2024-06-01)

Allogeneic Stem Cell Transplantation in Refractory Acute Myeloid Leukaemia
by: Roberto Bono, et al.
Published: (2024-04-01)

P395: PHARMACEUTICAL TARGETING OF RAS IN ACUTE MYELOID LEUKAEMIA
by: D. Coleman, et al.
Published: (2022-06-01)

Consensus on BCR-ABL1 reporting in chronic myeloid leukaemia in the UK
by: Cross, N, et al.
Published: (2018)

Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party.
by: Chessells, J, et al.
Published: (2002)